SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Dongwha Pharmaceutical Plans Tougher Penalties for Compliance Violations

Dongwha Pharmaceutical plans to strengthen penalties for violations of its fair-trade compliance program in Q4 2026, with corporate-card checks and on-site inspections.

Related stories